HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3)

The purpose of this grant is to support preclinical optimization and development of safe, effective, and non-addictive small molecule and biologic therapeutics to treat pain. The goal of the program is to accelerate the optimization and development of promising small molecule and biologic hits/leads.

Funding: No fixed limit 

Duration: 5 years 

Research Authority due date:  10 days prior to submission

LOI (encouraged) due dates: 18.10.20, 24.2.21, 14.6.21, 15.9.21, 15.1.22, 15.5.22

Full proposal due dates: 18.11.20, 24.3.21, 14.7.21, 15.10.21, 15.2.22, 15.6.22